Nautilus Biotechnology, Inc. (NASDAQ: NAUT) reported Q3 EPS of ($0.11), $0.08 better than the analyst estimate of ($0.19).

For earnings history and earnings-related data on Nautilus Biotechnology, Inc. (NAUT) click here.